JPRN-UMIN000018333已完成未知
Post marketing surveillance of Edirol - Post marketing surveillance of Edirol
Chugai Pharmaceutical Co.Ltd0 个研究点目标入组 3,000 人开始时间: 2015年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •No criteria
研究者
相似试验
招募中
4 期
A post marketing study to evaluate safety and effectiveness of Remogliflozin and Remogliflozin-Metformin Combination in treatment of Diabetes patientsCTRI/2019/11/022062Glenmark Pharmaceuticals Ltd
已完成
4 期
A post-marketing study of the marketed product Maxtra® P syrup for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031189Zuventus Healthcare Limited200
已完成
4 期
A post-marketing study of the marketed product Maxtra® P Tablets for the evaluation of safety and effects in children having common cold.CTRI/2021/02/031390Zuventus Healthcare Limited200
尚未招募
4 期
Study to evaluate safety of FDC of Evogliptin 5mg and Metformin hydrochloride IP (SR) 1000 mg film coated bilayered tablet available in marketCTRI/2020/08/027111Alkem Laboratories Limited
尚未招募
4 期
Safety and efficacy of Ayukalash on high blood pressure and cholesterol.CTRI/2024/05/067632Med Pharma CRO